| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 682,014 | 696,259 | 677,145 | 671,126 | | Cost of Revenue |
-
| 276,207 | 793,911 | (262,605) | | | Gross Profit | 682,014 | 420,052 | (116,766) | 933,731 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 358,445 | 44,862 | (471,123) | 570,900 | | Non Recurring |
-
| 73,438 | 8,009 | (2,283) | | Others | 132,119 | 139,164 | 136,705 | 130,053 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 191,450 | 162,588 | 209,643 | 235,061 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 117,737 | (77,071) | 43,545 | (30,759) | | Earnings Before Interest And Taxes | 309,187 | (70,756) | 206,791 | 253,002 | | Interest Expense | 147,707 | 142,506 | 148,039 | 150,316 | | Income Before Tax | 161,480 | (213,262) | 58,752 | 102,686 | | Income Tax Expense | 5,049 | 2,633 | 5,244 | 4,915 | | Minority Interest |
-
| (42,567) | 49,058 | (46,755) | | | | Net Income From Continuing Ops | 156,431 | (259,016) | 102,100 | 49,179 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 102 | 53,992 | | Extraordinary Items |
-
| 56,501 | (56,501) | 36,489 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 156,431 | (202,515) | 45,701 | 139,660 | | Preferred Stock And Other Adjustments | (30,590) | (14,271) | (14,271) | (14,274) | | | Net Income Applicable To Common Shares | $125,841 | ($216,786) | $31,430 | $125,386 |
|
0.45% Nasdaq 
0.20%
Income Statement
